Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Richard D. Kim | Researchclopedia

Back to researchers

Richard D. Kim

Moffitt Cancer Center

28

Works

479

Citations

7

h-index

6

i10-index

Research Topics

Fibroblast Growth Factor Research Kruppel-like factors research Cholangiocarcinoma and Gallbladder Cancer Studies

Affiliations

University of South Florida2020–2025

Moffitt Cancer Center2014–2026

Center for Human Genetics2004–2005

Top Works

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

Richard D. Kim,Debashis Sarker,et al.

2019245 citations

Hepatocellular Carcinoma Treatment and Prognosis

Cancer Immunotherapy and Biomarkers

Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma

Megan Hatlen,Oleg Schmidt-Kittler,et al.

2019108 citations

Improving identification of differentially expressed genes in microarray studies using information from public databases

Richard D. Kim,Peter J. Park

200439 citations

Updated dose escalation results for ReFocus, a first-in-human study of highly selective FGFR2 inhibitor RLY-4008 in cholangiocarcinoma and other solid tumors.

Mitesh J. Borad,Alison M. Schram,et al.

202336 citations

CrossChip: a system supporting comparative analysis of different generations of Affymetrix arrays

Sek Won Kong,Kyu‐Baek Hwang,et al.

200516 citations

Abstract IA006: Clinical activity of lirafugratinib (RLY-4008), a highly selective FGFR2 inhibitor, in patients with advanced FGFR2-altered solid tumors: The ReFocus study

Alison M. Schram,Vivek Subbiah,et al.

202311 citations

Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective

Xinrui Yang,Yin He,et al.

20208 citations

FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential

Hao Xie,Diego Alem,et al.

20216 citations

Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients.

Richard D. Kim,Steven R. Alberts,et al.

20146 citations